Comprehensive analysis of ECHDC3 as a potential biomarker and therapeutic target for acute myeloid leukemia: Bioinformatic analysis and experimental verification. - Zhao Y; Niu LT; Hu LJ; Lv M (Frontiers in oncology, 2022)